Clin2
NCT07686731Possibly a fitNot yet recruiting

Suvorexant for sleep problems in veterans with PTSD

PTSD - Post Traumatic Stress DisorderInsomniaTBI (Traumatic Brain Injury)

Treatments studied

Part of Brain & nervous system, Injuries & trauma, Mental health clinical trials.

This study tests whether the sleep medication suvorexant can improve insomnia in veterans who also have post-traumatic stress disorder (PTSD). It aims to see if treating sleep helps with PTSD symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
142 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are a U.S. military veteran aged 18 to 75.
  • You have been diagnosed with PTSD and have had symptoms for more than 3 months.
  • You have trouble sleeping, with a score above 14 on a standard insomnia questionnaire.
  • If you take other psychiatric medications, they must have been at the same dose for at least 4 weeks.
  • If you are in talk therapy, it must have been stable for at least 6 weeks, and you cannot be in exposure-based PTSD or insomnia-focused therapy.
  • If you are a woman who could become pregnant, you must have a negative pregnancy test and agree to use birth control during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06788522Not yet recruiting· Phase 4
Sleep medication for fear and sleep in veterans with PTSD

This study tests a new sleep medication (an orexin antagonist) to see if it helps Veterans with PTSD overcome fear and sleep better. It aims to improve how your brain handles fear responses.

San Francisco, California
NCT06679062Recruiting· Phase 2
Suvorexant for alcohol use disorder and PTSD

This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.

Los Angeles, California
NCT06655883Recruiting· Phase 3
Testing suvorexant for insomnia in people with opioid use disorder

This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.

Garden Grove, California
NCT05441280Recruiting· Phase 2
Pimavanserin to improve sleep in veterans with PTSD

This Phase 2 trial studies pimavanserin, a medicine meant to improve insomnia, in veterans who also have PTSD. It may help reduce problems with falling asleep, staying asleep, or waking too early that affect daytime functioning.

Houston, Texas
NCT05194930Recruiting
Insomnia treatment study for Veterans with PTSD symptoms

This study tests treatments to help Veterans who have both PTSD symptoms and trouble sleeping (insomnia). You may be invited to try study procedures to see what helps insomnia and whether it also improves sleep-related well-being.

Sepulveda, California
NCT05516277Recruiting
Insomnia care study for older adults with PTSD

This study tests a treatment plan for insomnia (trouble sleeping) in older adults who also have post-traumatic stress disorder (PTSD). The goal is to see whether improving sleep also supports heart and metabolic health (such as blood sugar and heart-related measures).

North Hills, California

Hear when a new Insomnia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.